Rejected from JAMA Network Open? Where to Submit Next

Archive protocol versions, registration timestamps, eligibility logic, recruitment flow, site list, treatment or exposure definitions, outcome definitions, missing-data decisions, exclusions, code, model specifications, diagnostics, sensitivity analyses, multiplicity plan, reporting checklists, data-sharing constraints, and repository state.

Write the contribution as clinical or policy question -> population -> intervention or exposure -> comparator -> outcome -> design -> estimate and uncertainty -> bias and sensitivity -> transportability -> patient, clinician, or policy decision. Mark each link as prespecified, observed, adjusted, exploratory, inferred, or missing.

Diagnose the JAMA Network Open rejection before rerouting.

A desk rejection commonly speaks to importance, broad relevance, study design, article type, topic saturation, recency, or an obvious reporting problem. It does not establish that the analysis is valid.

A post-review rejection after external review, including statistical review, is a validity audit. Reviewer comments about outcome switching, residual confounding, nonindependence, missing-data assumptions, overfitting, miscalibration, multiplicity, selective subgroup emphasis, or causal language can follow the manuscript anywhere.

A transfer offer or JAMA Network referral may preserve administrative work and reviews, but it does not lower the receiving journal's standard. Confirm the reader, article type, access cost, and whether a fully revised package can replace the transferred files.

JAMA Health Forum

Best for: policy, economics, access, quality, equity, delivery innovation, insurance, workforce, regulation, or health-system performance. Define the policy actor and decision.

Think twice if: policy relevance is one paragraph appended to a clinical association. The design and outcomes must answer a health-policy or delivery question.

A JAMA specialty journal

Best for: a decision owned by cardiologists, oncologists, neurologists, surgeons, psychiatrists, pediatricians, or another defined clinical group. Reframe the Introduction and Meaning around that field.

Think twice if: JAMA Network Open rejected the manuscript for design or validity. A narrower audience does not make confounding or reporting defects acceptable.

BMJ Open

Best for: transparent, methodologically sound clinical, public-health, and health-services studies where the value is the question and rigor rather than a high-priority general-medical claim.

Think twice if: the paper still overstates causality, hides exclusions, or lacks the correct reporting checklist. Open peer review makes those gaps more visible.

PLOS Medicine

Best for: work with substantial international relevance that can directly inform patient care, policy, or clinical research agendas. It can be an upward or lateral fit move, not a fallback.

Think twice if: JAMA Network Open's importance concern remains. PLOS Medicine is highly selective and explicitly prioritizes major health challenges.

BMC Medicine

Best for: broad, significant clinical, translational, epidemiological, public-health, or evidence-synthesis research with a clear general medical message.

Think twice if: the decision is highly specialty-specific or the manuscript is mainly a local service evaluation.

eClinicalMedicine

Best for: robust clinical or public-health evidence with a clear evidence-to-practice path, especially across diverse populations or settings.

Think twice if: the analysis is exploratory, underpowered, or unvalidated while the claims remain practice-changing.

Write a one-paragraph editor test naming population, intervention or exposure, comparator, outcome, design, estimate with absolute effect and uncertainty, principal bias, transportability, and reader decision. If the same paragraph fits every medical journal, the reader job is still unclear.

For a specialty route, lead with the specialty decision and why the outcome changes care in that field. Remove broad-medical claims the study cannot support.

For a health-policy route, define decision maker, policy lever, system, cost or equity outcome, implementation condition, and jurisdictional boundary.

For a sound-methods route, foreground protocol, design, transparent reporting, effect estimates, limitations, and reusable evidence. Do not manufacture importance language.

For a global medicine route, test burden, international relevance, setting diversity, access, equity, and whether conclusions transport beyond the source system.

Rewrite the title, Key Points, first two abstract sentences, main table, and conclusion. If the target framing needs a comparator, outcome, validation cohort, or policy analysis absent from the data, choose another destination or do the work.

For every headline claim, record prespecification, analysis population, missingness, clustering, covariates, model diagnostics, multiplicity, absolute effect, confidence interval, sensitivity results, and the population to which the conclusion applies.

Revise the title, Key Points, abstract, protocol and registration references, participant flow, methods, exposure and outcome definitions, statistical plan, main tables, figures, sensitivity analyses, reporting checklist, limitations, data-sharing statement, discussion, and conclusion together.

1. Name the reader decision: state what a patient, clinician, system leader, or policymaker can decide differently.
2. Align with prespecification: disclose protocol, registration, primary outcome, analysis plan, and deviations.
3. Rebuild the flow: reconcile screened, eligible, included, analyzed, missing, excluded, and followed participants.
4. Audit measurement: define exposures, interventions, outcomes, timing, adjudication, reliability, and misclassification.
5. Handle missingness: report patterns, assumptions, primary method, sensitivity analyses, and complete-case differences.
6. Control inference: address confounding, clustering, repeated measures, overfitting, calibration, and causal language.
7. Resolve multiplicity: distinguish primary, secondary, subgroup, sensitivity, and exploratory analyses.
8. Report clinical scale: provide absolute effects, uncertainty, baseline risk, harms, and meaningful thresholds.
9. Test transportability: compare sites, periods, populations, systems, and external evidence; bound generalization.
10. Complete reporting: use the correct EQUATOR guideline and make every checklist location accurate.

Audit the clinical evidence chain before resubmission.

Use a referral when the offered JAMA Network journal owns the revised reader and carrying reviews saves real work. Confirm the destination and replace weak files if allowed.

Appeal only when a concrete factual or procedural error could change the decision, such as an editor stating that the trial was unregistered when a prospective registration and date are clearly documented. Do not appeal a priority judgment by repeating the abstract.

Submit fresh when the center changes to policy, a specialty decision, transparent sound-methods publication, or global medicine. Close the prior process. Never submit the same manuscript to another journal simultaneously.

We inspect protocol, registration, eligibility, participant flow, exposure and intervention definitions, outcomes, missingness, models, diagnostics, multiplicity, absolute effects, reporting checklists, data statements, Key Points, tables, figures, and claims. These are qualitative Manusights patterns, not private JAMA decisions.

Pattern 1: association language becomes a treatment recommendation

For JAMA Network Open candidates, a retrospective or observational estimate may be statistically significant while the Meaning statement says practice should change. We map design to inference, add negative controls or sensitivity analyses where possible, and rewrite the conclusion around what the evidence supports.

We align the title, Key Points, abstract conclusion, Discussion, and patient implication so causal language does not survive in one high-visibility component.

Pattern 2: the flow diagram and analysis table describe different cohorts

In our JAMA Network Open review work, counts can differ across the abstract, flowchart, Table 1, model denominators, and supplement because exclusions or missing data were applied at different stages. We reconstruct one auditable participant ledger and regenerate outputs from it.

For medical manuscripts, this repair can matter more than additional prose because it restores trust in every estimate.

Pattern 3: relative effects hide a small absolute consequence

The abstract leads with an odds ratio or hazard ratio while baseline risk, absolute difference, confidence interval, and number affected are absent. We add the absolute scale and separate statistical from clinical importance.

We then revise the Key Points, main figure, results text, and conclusion so the importance claim follows the effect patients or systems actually experience.

Pattern 4: broad relevance is claimed from one system

A single hospital, insurer, registry, country, or pandemic period is described as general clinical evidence. We identify system-specific selection, coding, access, practice, and policy conditions, then test heterogeneity or narrow the target population.

We revise the setting description, limitations, policy paragraph, and conclusion together. Honest transport boundaries often reveal the right specialty or policy journal.

Choose the next journal only when the revised abstract can name the population, question, comparator, outcome, design, estimate and uncertainty, major bias, reporting standard, transportability boundary, and reader decision. Verify current scope, article type, access cost, and author instructions immediately before submission.

We checked current JAMA Network and destination guidance, the local Manusights owner inventory, and live exact-query results on July 13, 2026. We compared those public boundaries with the study-design, analysis, reporting, and clinical-claim evidence we inspect in medical reviews. Official sources establish scope and policy; the matrices, ledger, stress test, and review patterns are Manusights analysis.

Read final Search Console data after 14 complete days. At 21 complete days, keep, revise, consolidate, or stop based on indexation, exact-owner impressions, clicks, query fit, and qualified /ai-review starts. The source journal cluster had 9,956 impressions and no preview start; that does not prove exact rejection-query demand.